M&A Deal Summary

KD Pharma Group Acquires dsm-firmenich s Marine Lipids Omega-3 Business

On July 25, 2024, KD Pharma Group acquired chemicals company dsm-firmenich s Marine Lipids Omega-3 Business from DSM-Firmenich

Acquisition Highlights
  • This is KD Pharma Group’s 1st transaction in the Chemicals sector.
  • This is KD Pharma Group’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2024-07-25
Target dsm-firmenich s Marine Lipids Omega-3 Business
Sector Chemicals
Buyer(s) KD Pharma Group
Sellers(s) DSM-Firmenich
Deal Type Divestiture

Target

dsm-firmenich s Marine Lipids Omega-3 Business

Kaiseraugst, Switzerland
dsm-firmenich's Marine Lipids Omega-3 Business provides fish oil omega-3 business for the dietary supplement and pharma markets, together with the production facilities in Piura, Peru, and Mulgrave, Canada.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

KD Pharma Group

Bioggio, Switzerland

Category Company
Founded 1988
Sector Life Science
DESCRIPTION

KD Pharma Group is a CDMO that develops products in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer of API for Omega-3 pharmaceuticals and has built a similar market-leading position in Omega-3 nutraceuticals, formulation, and encapsulation services. KD Pharma Group was founded in 1988 and is based in Bioggio, Switzerland.


DEAL STATS #
Overall 2 of 2
Sector: Chemicals M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Switzerland M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-04 Trigal Pharma

Wien, Austria

Trigal Pharma is a pharmaceutical company that specializes in clinical research, development, and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. Trigal Pharma was formed in 2011 and is based in Wien, Austria.

Buy -

Seller(S) 1

SELLER

DSM-Firmenich

Kaiseraugst, Switzerland

Category Company
Founded 1902
Sector Chemicals
Employees26,301
Revenue 12.8B EUR (2024)
DESCRIPTION

DSM-Firmenich specializes in the development, manufacture, and marketing of performance materials, nutritional and pharmaceutical ingredients, and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing, and electrics & electronics. DSM-Firmenich was founded in 1902 and is based in Kaiseraugst, Switzerland.


DEAL STATS #
Overall 17 of 17
Sector: Chemicals M&A 7 of 7
Type: Divestiture M&A Deals 16 of 16
Country: Switzerland M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-31 DSM Engineering Materials

Heerlen, Netherlands

DSM Engineering Materials provides high-performance and increasingly sustainable thermoplastics used in automotive, electrical & electronics, building & construction, medical, food packaging, and consumer goods (to name but a few). Its materials enable lighter, stronger, and more durable products - which in turn makes people’s lives safer, more convenient, and healthier – and all while helping to tackle carbon emissions. DSM Engineering Materials is based in Heerlen, Netherlands.

Sell €3.7B